ENAH and non-Hodgkin lymphoma: Those who were positive for at least one other autoantibody (anti-ENA or anti-dsDNA) were discovered to have a roughly three-fold increase in the risk of developing NHL overall compared to those who tested negative (OR: 2.93, 95% CI: 1.18–7.28, p = 0.02, Table 3) or those who were untested (OR: 3.01, 95% CI: 1.27–7.15, p = 0.01, Supplementary Table S3).